Search

Your search keyword '"Ferman, Tanis J"' showing total 77 results

Search Constraints

Start Over You searched for: Author "Ferman, Tanis J" Remove constraint Author: "Ferman, Tanis J" Publisher wiley Remove constraint Publisher: wiley
77 results on '"Ferman, Tanis J"'

Search Results

1. Lewy body dementia: Overcoming barriers and identifying solutions

3. Comparative assessment of α‐synuclein seeding activities in the cerebrospinal fluid of MCI patients phenoconverting to DLB

4. Automated Analysis of REM Sleep without Atonia in the Lewy Body Disease Spectrum

6. Plasma biomarkers of Alzheimer´s disease in the continuum of dementia with Lewy bodies

7. Alzheimer’s disease biomarkers of amyloid and tau influence white matter neurite alterations in dementia with Lewy bodies: a NODDI study

8. Amyloid PET in the Lewy Body disease continuum

9. Baseline and Longitudinal Ioflupane SPECT Findings in DLB and MCI‐LB

10. Longitudinal Tau Positron Emission Tomography in Dementia with Lewy Bodies

11. Brief smell identification test performance in RBD, DLB and AD

12. Potential utility of longitudinal 123I‐FP‐CIT SPECT imaging in predicting phenoconversion to overt synucleinopathy in isolated REM sleep behavior disorder

13. Evolution of core features in Lewy body disease pathologic subtypes

14. The temporal onset of the core features in dementia with Lewy bodies

15. MRI quantitative susceptibility mapping of the substantia nigra as an early biomarker for Lewy body disease

16. Evolution of the core clinical features of dementia with Lewy bodies

17. Utility of ioflupane‐SPECT with multimodal imaging in dementia with Lewy bodies

18. Functional connectivity is associated with tau spreading in dementia with Lewy bodies

19. Quantitative susceptibility mapping of substantia nigra in dementia with Lewy bodies

21. P3-427: MILD COGNITIVE IMPAIRMENT PROGRESSING TO DEMENTIA WITH LEWY BODIES: REGIONAL ATROPHY RATES AND RELATIONSHIP TO AV-1451 UPTAKE

22. O1‐04‐05: PATHOLOGIC ASSOCIATIONS OF FDG PET IN LEWY BODY DISEASE

23. O4-03-03: CLINICAL CHARACTERIZATION OF MILD COGNITIVE IMPAIRMENT ASSOCIATED WITH EVENTUAL LEWY BODY DISEASE PATHOLOGY

24. IC-02-03: MILD COGNITIVE IMPAIRMENT PROGRESSING TO DEMENTIA WITH LEWY BODIES: REGIONAL ATROPHY RATES AND RELATIONSHIP TO AV-1451 UPTAKE

25. A proteomic signature for dementia with Lewy bodies

27. IC‐P‐019: LONGITUDINAL ACCUMULATION OF β‐AMYLOID ON PET IN DEMENTIA WITH LEWY BODIES AND RELATIONSHIP TO CLINICAL DISEASE PROGRESSION

28. P3‐424: LONGITUDINAL ACCUMULATION OF β‐AMYLOID ON PET IN DEMENTIA WITH LEWY BODIES AND RELATIONSHIP TO CLINICAL DISEASE PROGRESSION

30. Full sequencing and haplotype analysis of MAPT in Parkinson's disease and rapid eye movement sleep behavior disorder

31. Clinicopathological and 123 I-FP-CIT SPECT correlations in patients with dementia

32. The limbic and neocortical contribution of α‐synuclein, tau, and amyloid β to disease duration in dementia with Lewy bodies

34. [IC-P-075]: PATTERN OF HYPOPERFUSION ON ASL OVERLAPS WITH HYPOMETABOLISM ON FDG-PET IN DEMENTIA WITH LEWY BODIES

35. [P1-483]: LONGITUDINAL PERFORMANCE ON THE KING DEVICK TEST IN PATIENTS WITH REM SLEEP BEHAVIOR DISORDER +/- MILD COGNITIVE IMPAIRMENT

36. [P1-334]: CHARACTERIZATION OF THE CLINICAL AND NEUROIMAGING FEATURES OF PATIENTS WITH DEMENTIA WITH LEWY BODIES ASSOCIATED WITH VARIANTS IN GLUCOCEREBROSIDASE (GBA)

37. [P1-393]: PATTERN OF HYPOPERFUSION ON ASL OVERLAPS WITH HYPOMETABOLISM ON FDG-PET IN DEMENTIA WITH LEWY BODIES

38. Phenoconversion from probable rapid eye movement sleep behavior disorder to mild cognitive impairment to dementia in a population‐based sample

39. AV-1451 tau and β-amyloid positron emission tomography imaging in dementia with Lewy bodies

40. An investigation of cerebrovascular lesions in dementia with Lewy bodies compared to Alzheimer's disease

41. Arguing against the proposed definition changes of PD

42. O4‐01‐01: Pattern of AV‐1451 Uptake in Dementia with Lewy Bodies and its Association with Amyloid‐Beta Deposition

43. P2-201: Pathologic Predictors of Disease Duration in Lewy Body Disease

44. MAPT haplotype H1G is associated with increased risk of dementia with Lewy bodies

45. Predicting Survival in Dementia With Lewy Bodies With Hippocampal Volumetry

48. P4-245: Predicting survival in dementia with lewy bodies: The importance of hippocampal volume

49. O2-10-06: Frequency and distribution of cerebral microbleeds in dementia with lewy bodies

50. P1-178: Frequency of cerebral infarcts in probable dementia with lewy bodies

Catalog

Books, media, physical & digital resources